The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $28,235,184.10 and a period of performance through January 31, 2028.
The contract is intended to provide a national supply source for various pharmaceutical products, including but not limited to ibuprofen, citalopram, albuterol, lisinopril, pregabalin, escitalopram oxalate, oseltamivir phosphate, prazosin HCL, sildenafil citrate, and zonisamide. These medications are to be delivered in various dosages and package sizes to support the healthcare needs of the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through their respective prime vendor programs. The contract was awarded on an unrestricted basis, allowing Exelan Pharmaceuticals to compete based on its capabilities and pricing. The contract is primarily structured as firm fixed-price deliverables, with Exelan performing the work at its facility in Boca Raton, Florida.
Generated 3/20/25, 9:51 AM